House Energy & Commerce committee chair Frank Pallone (D-NJ) (Kevin Dietsch/Pool via AP Images)

Com­plete­ly clean FDA-in­dus­try user fee deal at­tached to a must-pass gov­ern­ment spend­ing bill

With four days left in the fis­cal year, FDA-re­lat­ed pol­i­cy rid­ers ap­proved in both House and Sen­ate com­mit­tees, at least for now, ap­pear dead, ac­cord­ing to the text of a short-term gov­ern­ment spend­ing bill un­veiled late last night to keep fed­er­al agen­cies open un­til Dec. 16.

But the ab­sence of rid­ers (both sides pre­vi­ous­ly an­nounced a “prac­ti­cal­ly clean” deal last week) doesn’t mean De­moc­rats are done fight­ing to add these ac­cel­er­at­ed ap­provals and oth­er reg­u­la­to­ry re­forms for cos­met­ics, nu­tri­tion­al prod­ucts and di­ag­nos­tic tests.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.